e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
An update on the mechanisms of pulmonary oedema formation and reabsorption
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Strengths and limitations of β
2
agonists in the treatment of oedema during ALI
F. Grimbert (La Tronche, France)
Source:
Annual Congress 2005 - An update on the mechanisms of pulmonary oedema formation and reabsorption
Session:
An update on the mechanisms of pulmonary oedema formation and reabsorption
Session type:
Symposium
Number:
3134
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Grimbert (La Tronche, France). Strengths and limitations of β
2
agonists in the treatment of oedema during ALI. Annual Congress 2005 - An update on the mechanisms of pulmonary oedema formation and reabsorption
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
A novel approach for optimal lung recruitment in acute lung injury
Source: Annual Congress 2005 - Pulmonary function outcome, respiratory morbidity in prematurely born children and acute lung injury
Year: 2005
Mechanisms of acute lung injury
Source: Annual Congress 2005 -
In vivo
- approaches to lung injury
Year: 2005
Acute lung injury as a possible adverse drug reaction related to gefitinib
Source: Eur Respir J 2002 Jan 01;22(1):179-181
Year: 2003
Ventilator-associated lung injury: a search for better therapeutic targets
Source: Eur Respir J 2007; 30: 1216-1226
Year: 2007
Resolution of acute lung injury and inflammation: a translational mouse model
Source: Eur Respir J 2012; 39: 1162-1170
Year: 2012
Ventilator-induced lung injury
Source: Eur Respir J 2003; 22: 2S-9S
Year: 2003
Pre-treatment with mesenchymal stem cells reduces ventilator-induced lung injury},
Source: Eur Respir J 2012; 40: 939-948
Year: 2012
Drug-induced ILD
Source: Annual Congress 2007 - PG5 - Interstitial lung diseases: known causes and systemic disorders
Year: 2007
Salmeterol prevents pneumonia and reduces biomarkers of inflammation/epithelial damage but not acute lung injury following oesophagectomy-the results of BALTI-prevention trial
Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights
Year: 2013
Early short-term versus prolonged low-dose methylprednisolone therapy in acute lung injury
Source: Eur Respir J 2009; 33: 634-645
Year: 2009
Cardiopulmonary effects of iloprost in experimental acute lung injury
Source: Eur Respir J 2005; 25: 81-87
Year: 2005
Unilateral treatment with lung volume reduction coils in patients with severe emphysema
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013
Mechanical ventilation interacts with experimental low dose endotoxemia to induce apoptotic lung responses in mice
Source: Annual Congress 2005 -
In vivo
- approaches to lung injury
Year: 2005
Salutary effect of fructose-1,6-diphosphate in lung injury: a randomized double-blinded placebo clinical trial
Source: Annual Congress 2007 - Lung recruitment
Year: 2007
The use of surfactant in severe reperfusion injury after lung transplantation
Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation
Year: 2005
Hsp90 binding inhibitors improve survival in a murine model of sepsis induced acute lung injury
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006
Effect of prior statin therapy on capillary permeability in the lungs after cardiac or vascular surgery
Source: Eur Respir J 2006; 27: 1026-1032
Year: 2006
Pioglitazone attenuates endotoxin-induced acute lung injury by reducing neutrophil recruitment
Source: Eur Respir J 2012; 40: 416-423
Year: 2012
Elastase-induced emphysema: Species differences in markers of acute lung injury relate to the magnitude of emphysema development
Source: Annual Congress 2010 - Proteases and the matrix
Year: 2010
Increased injury and intramuscular collagen of the diaphragm in COPD: autopsy observations
Source: Eur Respir J 2006; 27: 51-59
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept